Results

Oxurion NV

11/15/2021 | Press release | Distributed by Public on 11/15/2021 00:24

First Patient Dosed in Part B of Phase 2 KALAHARI Study Evaluating Multiple Administrations of THR-149 versus aflibercept for Treatment of Diabetic Macular Edema (DME)